This company listing is no longer active
CTI BioPharma Dividends and Buybacks
Dividend criteria checks 0/6
CTI BioPharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-5.3%
Buyback Yield
Total Shareholder Yield | -5.3% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
CTI BioPharma: Reiterating Target Price Of $17 After Successful VONJO Launch
Aug 17CTI BioPharma GAAP EPS of -$0.21 misses by $0.01, revenue of $12.33M beats by $3.23M
Aug 08CTI BioPharma: Approval Is Great, Now There's The Follow Through
Jul 19CTI BioPharma initiated at outperform at Cowen on potential for Vonjo for myelofibrosis
Jul 07CTI BioPharma - 3.2x Potential Upside On A De-Risked Asset
May 04CTI BioPharma Corp.: Pacritinib Approval, Downgrade To A Sell Rating
Apr 11CTI BioPharma: A Speculative Buy Into The PDUFA Date
Mar 01CTI BioPharma: Long And Troubled History, Finally Approaching Approval
Dec 24FDA grants 'priority review' status to CTI Biopharma's pacritinib NDA
Jun 01CTI BioPharma initiated buy at Stifel; cites potential in myelofibrosis
May 06CTI BioPharma: Accelerated Approval Pathway Looks Attractive
Dec 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if CTIC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CTIC's dividend payments have been increasing.
Dividend Yield vs Market
CTI BioPharma Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (CTIC) | n/a |
Market Bottom 25% (US) | 1.4% |
Market Top 25% (US) | 4.2% |
Industry Average (Biotechs) | 2.3% |
Analyst forecast (CTIC) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate CTIC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CTIC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CTIC has not reported any payouts.